Diabetic Retinopathy Market Report

Diabetic Retinopathy Market Analysis Report Size, Share & Trends Analysis Report By Type (Proliferative DR, Non-proliferative DR), By Management (Anti-VEGF Therapy, Vitrectomy), And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-466-6
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Diabetic Retinopathy Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Proliferative Diabetic Retinopathy
    • Non-proliferative Diabetic Retinopathy
  • Diabetic Retinopathy Management Outlook (Revenue, USD Million, 2018 - 2030)
    • Anti-VEGF
    • Intraocular Steroid Injection
    • Laser Surgery
    • Vitrectomy
  • Diabetic Retinopathy Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Diabetic Retinopathy market, By Type
        • Proliferative Diabetic Retinopathy
        • Non-proliferative Diabetic Retinopathy
      • North America Diabetic Retinopathy market, by Management
        • Anti-VEGF
        • Intraocular Steroid Injection
        • Laser Surgery
        • Vitrectomy
      • U.S.
        • U.S. Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • U.S. Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
      • Canada
        • Canada Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • Canada Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
    • Europe
      • Europe Diabetic Retinopathy market, By Type
        • Proliferative Diabetic Retinopathy
        • Non-proliferative Diabetic Retinopathy
      • Europe Diabetic Retinopathy market, by Management
        • Anti-VEGF
        • Intraocular Steroid Injection
        • Laser Surgery
        • Vitrectomy
      • U.K.
        • U.K. Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • U.K. Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
        • Germany
          • Germany Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Germany Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • France
          • France Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • France Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Spain
          • Spain Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Spain Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Italy
          • Italy Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Italy Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Denmark
          • Denmark Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Denmark Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Sweden
          • Sweden Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Sweden Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Norway
          • Norway Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Norway Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
      • Asia Pacific
        • Asia Pacific Diabetic Retinopathy market, By Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • Asia Pacific Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
        • China
          • China Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • China Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Japan
          • Japan Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Japan Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • India
          • India Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • India Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • South Korea
          • South Korea Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • South Korea Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Thailand
          • Thailand Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Thailand Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
        • Australia
          • Australia Diabetic Retinopathy market, by Type
            • Proliferative Diabetic Retinopathy
            • Non-proliferative Diabetic Retinopathy
          • Australia Diabetic Retinopathy market, by Management
            • Anti-VEGF
            • Intraocular Steroid Injection
            • Laser Surgery
            • Vitrectomy
    • Latin America
      • Latin America Diabetic Retinopathy market, By Type
        • Proliferative Diabetic Retinopathy
        • Non-proliferative Diabetic Retinopathy
      • Latin America Diabetic Retinopathy market, by Management
        • Anti-VEGF
        • Intraocular Steroid Injection
        • Laser Surgery
        • Vitrectomy
      • Brazil
        • Brazil Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • Brazil Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
      • Mexico
        • Mexico Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • Mexico Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
      • Argentina
        • Argentina Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • Argentina Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
    • Middle East and Africa
      • Middle East and Africa Diabetic Retinopathy market, By Type
        • Proliferative Diabetic Retinopathy
        • Non-proliferative Diabetic Retinopathy
      • Middle East and Africa Diabetic Retinopathy market, by Management
        • Anti-VEGF
        • Intraocular Steroid Injection
        • Laser Surgery
        • Vitrectomy
      • South Africa
        • South Africa Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • South Africa Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
      • Saudi Arabia
        • Saudi Arabia Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • Saudi Arabia Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
      • UAE
        • UAE Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • UAE Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy
      • Kuwait
        • Kuwait Diabetic Retinopathy market, by Type
          • Proliferative Diabetic Retinopathy
          • Non-proliferative Diabetic Retinopathy
        • Kuwait Diabetic Retinopathy market, by Management
          • Anti-VEGF
          • Intraocular Steroid Injection
          • Laser Surgery
          • Vitrectomy

Diabetic Retinopathy Market Dynamics

Driver: Increasing Prevalence Of Diabetes

The rise in prevalence of diabetes due to obesity, aging, and unhealthy lifestyles is contributing to the growth of the diabetic retinopathy market. Obesity is a major factor leading to diabetes. The International Diabetes Federation (IDF) estimated l537 million adults (aged 20 to 79 years) were living with diabetes in 2021, which is expected to rise to 642 million by 2040. According to WHO, in 2021, around 39% of adults aged 18 years and above were overweight, and 13% were obese worldwide. In addition to obesity, diabetes is becoming increasingly prevalent globally. The rise in obesity and diabetes is attributed to unhealthy diets, sedentary lifestyles, and heredity. These conditions can increase the risk of other health problems, including heart disease, stroke, and cancer. For instance, according to the CDC, 122.4 million people have prediabetes, of which 96 million are aged 18 years & above, and 26.4 million are aged 65 years & above.

Driver: Increasing Prevalence Of Blindness Due To Diabetes

The increasing prevalence of blindness due to diabetes is contributing to the growth of the diabetic retinopathy market. The prevalence of diabetic retinopathy in the U.S. is expected to increase rapidly. According to a report published by WHO, diabetic retinopathy is responsible for 4.8% of the 37 million blindness cases in the world.Diabetic retinopathy is a microvascular complication of type I and type II diabetes. It can progress to sight-threatening stages, which can cause blindness and visual impairment if not treated.According to an American Diabetes Association report, a diabetic person is at risk for diabetes-related eye diseases, such as cataracts, diabetic retinopathy, macular edema, and glaucoma. Diabetic retinopathy is a leading cause of blindness among U.S. adults.

Restraint: Adverse Effects Of Treatment

Several adverse effects related to the treatment options for diabetic retinopathy, including inflammatory & non-inflammatory complications of intravitreal Anti-VEGF infections.

What Does This Report Include?

This section will provide insights into the contents included in this diabetic retinopathy market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Diabetic retinopathy market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Diabetic retinopathy market quantitative analysis

  • Market size, estimates, and forecast from 2018 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon